|
ZA989389B
(en)
*
|
1997-11-14 |
2000-04-14 |
Lilly Co Eli |
Pyrrolo [3,2-b] pyridine processes and intermediates.
|
|
US5905084A
(en)
*
|
1997-11-14 |
1999-05-18 |
Eli Lilly And Company |
5-HTIF -agonists effective in treating migraine
|
|
US6133290A
(en)
*
|
1998-07-31 |
2000-10-17 |
Eli Lilly And Company |
5-HT1F agonists
|
|
GB9823845D0
(en)
*
|
1998-11-02 |
1998-12-23 |
Lilly Co Eli |
Pharmaceutical compounds
|
|
US6608079B1
(en)
|
1998-12-11 |
2003-08-19 |
Eli Lilly And Company |
Indole derivatives and their use as 5-HT1F agonists
|
|
EP1465869B1
(en)
|
2001-12-21 |
2013-05-15 |
Exelixis Patent Company LLC |
Modulators of lxr
|
|
US7482366B2
(en)
|
2001-12-21 |
2009-01-27 |
X-Ceptor Therapeutics, Inc. |
Modulators of LXR
|
|
TWI263497B
(en)
*
|
2002-03-29 |
2006-10-11 |
Lilly Co Eli |
Pyridinoylpiperidines as 5-HT1F agonists
|
|
ES2201899B1
(es)
*
|
2002-04-01 |
2005-06-01 |
Almirall Prodesfarma, S.A. |
Derivados de la azaindolilpiperidina como agentes antihistaminicos y antialergicos.
|
|
ES2388547T3
(es)
|
2003-04-18 |
2012-10-16 |
Eli Lilly And Company |
Compuestos de (piperidiniloxi)fenilo, (piperidiniloxi)piridinilo, (piperidinilsulfanil)fenilo y (piperidinilsulfanil)piridinilo como agonistas de 5-HT 1F
|
|
UA82711C2
(en)
|
2003-09-12 |
2008-05-12 |
Эли Лилли Энд Компани |
Substituted 2-carbonylamino-6-piperidinaminopyridines and substituted 1-carbonylamino-3-piperidinaminobenzenes as 5-ht1f agonists
|
|
BRPI0416852A
(pt)
*
|
2003-11-21 |
2007-02-27 |
Array Biopharma Inc |
inibidores da quinase akt
|
|
DE602004008338T2
(de)
|
2003-12-17 |
2008-05-29 |
Eli Lilly And Co., Indianapolis |
Substituierte (4-aminocyclohexen-1-yl) phenyl and (4-aminocyclohexen-1-yl) pyridinyl verbindungen als 5-ht1f agonisten
|
|
US8063050B2
(en)
*
|
2006-07-06 |
2011-11-22 |
Array Biopharma Inc. |
Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors
|
|
WO2008006025A1
(en)
|
2006-07-06 |
2008-01-10 |
Array Biopharma Inc. |
Dihydrofuro pyrimidines as akt protein kinase inhibitors
|
|
PL2049500T3
(pl)
*
|
2006-07-06 |
2012-02-29 |
Array Biopharma Inc |
Cyklopenta[d]pirymidyny jako inhibitory kinaz białkowych AKT
|
|
WO2008006039A1
(en)
|
2006-07-06 |
2008-01-10 |
Array Biopharma Inc. |
Dihydrothieno pyrimidines as akt protein kinase inhibitors
|
|
BRPI0813999A2
(pt)
|
2007-07-05 |
2019-10-01 |
Array Biopharma Inc |
ciclopentanos de pirimidil como inibidores de akt proteína cinase
|
|
US8846683B2
(en)
|
2007-07-05 |
2014-09-30 |
Array Biopharma, Inc. |
Pyrimidyl cyclopentanes as Akt protein kinase inhibitors
|
|
US9409886B2
(en)
|
2007-07-05 |
2016-08-09 |
Array Biopharma Inc. |
Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
|
|
EP2404907B1
(en)
*
|
2007-07-05 |
2015-01-14 |
Array Biopharma, Inc. |
Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
|
|
AU2009204019B2
(en)
*
|
2008-01-09 |
2014-02-20 |
Array Biopharma Inc. |
Hydroxylated pyrimidyl cyclopentane as AKT protein kinase inhibitor
|
|
KR101624753B1
(ko)
*
|
2008-01-09 |
2016-05-26 |
어레이 바이오파마 인크. |
Ａｋｔ 단백질 키나제 저해물질로서의 수산화된 피리미딜 시클로펜탄
|
|
EP2413933B2
(en)
*
|
2009-04-02 |
2021-06-09 |
Colucid Pharmaceuticals, Inc. |
2,4,6-trifluoro-n-[6-(1-methyl-piperidin-4-carbonyl)-pyridin-2-yl]-benzamide for the treatment of migraine via the oral or intravenous route
|
|
US8697876B2
(en)
|
2010-04-02 |
2014-04-15 |
Colucid Pharmaceuticals, Inc. |
Compositions and methods of synthesis of pyridinolypiperidine 5-HT1F agonists
|
|
CA2831922C
(en)
|
2011-04-01 |
2019-12-31 |
Genentech, Inc. |
Combinations of akt inhibitor compounds and vemurafenib, and methods of use
|
|
BR112013025397A2
(pt)
|
2011-04-01 |
2019-09-24 |
Deepak Sampath |
combinação de um composto, composto de fórmula i ou um sal farmaceuticamente aceitável do mesmo, uso, kit, produto, método para tratamento de um distúrbio hiperproliferativo e método para tratamento de uma doença ou afecção modulada por quinase akt em um mamífero
|
|
BG111544A
(bg)
|
2013-07-29 |
2015-01-30 |
Николай Цветков |
Субституирани бензамидни производни като in vitro mao-b инхибитори
|
|
ES2685839T3
(es)
*
|
2013-08-02 |
2018-10-11 |
Pfizer Inc. |
Inhibidores de RORC2 heterobicicloarilo y procedimientos de uso de los mismos
|
|
MA40759A
(fr)
|
2014-09-26 |
2017-08-01 |
Pfizer |
Modulateurs de rorc2 de type pyrrolopyridine substitué par un méthyle et trifluorométhyle et leurs procédés d'utilisation
|
|
US9771366B2
(en)
*
|
2016-02-19 |
2017-09-26 |
Phoenix Molecular Design |
Substituted tetrahydropyrido[3′,2′:4,5]pyrrolo[1,2-a]pyrazine-2-carboxamides as RSK inhibitors
|
|
US11858910B2
(en)
|
2018-08-24 |
2024-01-02 |
Sunshine Lake Pharma Co., Ltd. |
Pyridinylmethylenepiperidine derivatives and uses thereof
|
|
TWI826514B
(zh)
|
2018-09-04 |
2023-12-21 |
美商美國禮來大藥廠 |
用於預防偏頭痛之拉米迪坦(lasmiditan)長期夜間投藥
|
|
EP3924352A4
(en)
|
2019-02-11 |
2022-11-16 |
Phoenix Molecular Designs |
CRYSTALLINE FORMS OF AN RSK INHIBITOR
|
|
TWI776175B
(zh)
|
2019-07-09 |
2022-09-01 |
美商美國禮來大藥廠 |
大規模製備2,4,6-三氟-n-[6-(1-甲基-哌啶-4-羰基)-吡啶-2-基]-苯甲醯胺半琥珀酸鹽的方法及中間體，以及2,4,6-三氟-n-[6-(1-甲基-哌啶-4-羰基)-吡啶-2-基]-苯甲醯胺醋酸鹽之製備
|